11:34 AM EDT, 05/28/2024 (MT Newswires) -- Ensysce Biosciences ( ENSC ) said Tuesday it has been notified by Nasdaq that it is compliant with the exchange's equity requirement for continued listing.
As a result, Ensysce shares will continue trading on the Nasdaq's Capital Market tier, the clinical stage pharmaceutical company said.
Ensysce shares were 1.4% higher in recent trading.
Price: 0.58, Change: +0.01, Percent Change: +1.40